Bicycle Therapeutics plc - American Depositary Shares — Balance Sheet (NASDAQ:BCYC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 161.15 M479.79 M410.61 M595.34 M956.87 M717.6 M Total liabilities 65.69 M133.54 M139.83 M224.41 M163.81 M107.62 M Total equity 95.46 M346.25 M270.78 M370.93 M793.06 M609.98 M Total liabilities & shareholders' equities 161.15 M479.79 M410.61 M595.34 M956.87 M717.6 M Total debt 14.51 M29.87 M30.32 M30.7 M30.87 M— Net debt 14.93 M-396.75 M-294.83 M-481.47 M-839.5 M—

News

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Morgan Stanley reiterates Bicycle Therapeutics stock rating on program shift

Bicycle Therapeutics earnings beat by $0.65, revenue topped estimates

Seres names Richard Kender as executive chair and interim CEO

Bicycle Therapeutics announces leadership changes for next phase

Oppenheimer reiterates Outperform rating on Bicycle Therapeutics stock

Bicycle Therapeutics stock rating reiterated at Market Outperform by Citizens

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Truist Securities initiates coverage on Bicycle Therapeutics stock with Hold rating

Bicycle Therapeutics stock price target raised to $12 from $10 at Citizens

This Itron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Comcast (NASDAQ:CMCSA), Bicycle Therapeutics (NASDAQ:BCYC)

RBC Capital downgrades Bicycle Therapeutics stock on delayed pipeline progress